In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.
Age
18–95
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients with recurrent mitral regurgitation treated with a MitraClip®.